https://mobirise.com/

Alexander von Humboldt Kolleg
Current Advances on Neurodegeneration: from Molecular Biology to Translational Medicine.

Córdoba, Argentina - September 28 to October 1, 2017

Aim of the program |

The Alexander von Humbodt (AvH) Kolleg Current Advances on Neurodegeneration: from Molecular Biology to Translational Medicine aims to bring together scientists from Germany and Argentina interested in basic and applied research on Neurodegenerative Diseases. One major objective of the Kolleg will be to provide members of the Argentine scientific community, and especially young individuals working on neurodegenerative diseases with a focused and timely event where they will present their research and actively interact with local and international recognized scientists working in this field. 

The proposed Kolleg also seeks to revitalize the Alexander von Humboldt Club Argentina, which in 2017 reaches 50 years of existence. This important Anniversary is the opportunity to invite the president of the AvH Foundation, Prof. Dr. Helmut Schwarz to share the days of the Kolleg in Cordoba, home town of the National University of Córdoba (UNC,www.unc.edu.ar) one of the largest and oldest universities of Latin America.

The Kolleg will include key note Lectures and special lectures by internationally recognized scientists and AvH research awardees. It will be divided in 8 sessions of 30 min oral presentations on selected topics by invited scientists from Argentina and 3 poster sessions devoted to current research by junior investigators, postdoctoral fellows and doctorate students (see Full Program). The third poster session will allow the presentation of scientific advances in different fields by the Alexander von Humboldt Alumni community with the aim of generate interdisciplinary interactions among them. An extension of the program will be a final round table to be held at the University Cordoba after the 3 days of sessions, dedicated to students, professors and investigators to work out different dimensions of neurodegenerative diseases, to expand current advances to a broader public as well as disseminate the work of the Humboldt Foundation supporting science all over the world.